Combined Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The combined ratio is calculated by taking the sum of incurred losses and expenses and then dividing them by earned premium. Calculated as: Total Operating Expenses / Net Premiums Earned
Ultragenyx Pharmaceutical Inc. (RARE) Combined Ratio data is not available.
| Income Statement Financials | |
$560.23M |
|
$-569.18M |
|
$76.73M |
|
$483.50M |
|
$1.10B |
|
$-535.97M |
|
$-31.61M |
|
$-567.59M |
|
$-567.59M |
|
$-569.18M |
|
$-569.18M |
|
$-569.18M |
|
$-569.18M |
|
$-535.97M |
|
$-513.05M |
|
90.54M |
|
90.54M |
|
$-6.29 |
|
$-6.29 |
|
| Balance Sheet Financials | |
$817.12M |
|
$265.93M |
|
$686.33M |
|
$1.50B |
|
$344.15M |
|
-- |
|
$904.01M |
|
$1.25B |
|
$255.30M |
|
$32.58M |
|
$255.30M |
|
92.48M |
|
| Cash Flow Statement Financials | |
$-414.19M |
|
$-17.77M |
|
$399.24M |
|
$219.40M |
|
$184.16M |
|
$-35.24M |
|
$158.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.30% |
|
-95.67% |
|
-95.67% |
|
-91.58% |
|
-101.31% |
|
-101.60% |
|
$-421.68M |
|
-- |
|
-- |
|
|
Combined Ratio |
-- |
0.37 |
|
1.70 |
|
4.60 |
|
79.36 |
|
-222.95% |
|
-1747.19% |
|
-37.86% |
|
-222.95% |
|
$2.76 |
|
$-4.66 |
|
$-4.57 |
|